10.84

4.69% 0.485

After Hours: 10.50 -0.335 -3.09%

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $10.84, with a volume of 117.53K. It is up +4.69% in the last 24 hours and up +34.10% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Previous Close:

$10.35

Open:

$10.38

24h Volume:

117.53K

Relative Volume:

0.09

Market Cap:

$86.20M

Revenue:

$49.09M

Net Income/Loss:

$-52.15M

P/E Ratio:

-16.67

EPS:

-0.65

Net Cash Flow:

$-45.93M

1W Performance:

+8.79%

1M Performance:

+34.10%

6M Performance:

+31.81%

1Y Performance:

-42.37%

1-Day Range:

$9.83

$11.00

1-Week Range:

$9.8101

$11.00

52-Week Range:

$3.436

$20.40

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1112)

Industry

Diagnostics & Research (52)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

273

Twitter

Next Earnings Date

2025-10-31

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	10.84	82.34M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	509.82	198.06B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	214.94	155.50B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	617.20	51.80B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	124.88	36.46B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	319.83	32.29B	3.17B	642.63M	539.81M	10.77

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

Feb 12, 2026

Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Declines By 48.4% - MarketBeat

Feb 12, 2026

Biodesix, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative

Feb 12, 2026

Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times

Feb 12, 2026

Feb 11, 2026

Biodesix (NASDAQ:BDSX) CEO Scott Hutton Sells 3,559 Shares - MarketBeat

Feb 11, 2026

Feb 10, 2026

What is Biodesix Inc. s 5 year growth outlookQuarterly Investment Review & AI Based Buy and Sell Signals - mfd.ru

Feb 10, 2026

Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 10, 2026

Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Feb 10, 2026

Feb 03, 2026

Can Biodesix Sustain Its Growth Momentum In 2026? - RTTNews

Feb 03, 2026

Jan 30, 2026

Telemark Asset Management, LLC Increases Stake in Biodesix Inc - GuruFocus

Jan 30, 2026

Jan 28, 2026

What is the dividend yield of Biodesix IncWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Jan 28, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 82,465 Shares - Defense World

Jan 28, 2026

Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Increases By 499.1% - MarketBeat

Jan 28, 2026

Jan 27, 2026

Hedge Fund and Insider Trading News: Seth Klarman, Dan Loeb, Michael Burry, Michael Platt, Bridgewater Associates, Greenlight Capital, Biodesix Inc (BDSX), UWM Holdings Corp (UWMC), and More - Insider Monkey

Jan 27, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 80,000 Shares - MarketBeat

Jan 27, 2026

Biodesix (NASDAQ:BDSX) Director Acquires $236,000.00 in Stock - MarketBeat

Jan 27, 2026

Biodesix director Schuler buys $1.1m+ in BDSX stock By Investing.com - Investing.com South Africa

Jan 27, 2026

Biodesix director Schuler buys $1.1m+ in BDSX stock - Investing.com

Jan 27, 2026

Jan 26, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Buys 82,465 Shares - MarketBeat

Jan 26, 2026

Biodesix (BDSX) emeritus director Schuler buys $903k in stock By Investing.com - Investing.com Nigeria

Jan 26, 2026

Biodesix (BDSX) emeritus director Schuler buys $903k in stock - Investing.com

Jan 26, 2026

Perkins Capital Management Inc. Has $397,000 Position in Biodesix, Inc. $BDSX - MarketBeat

Jan 26, 2026

Jan 25, 2026

Big Money Moves: Can Biodesix Inc expand into new marketsTrade Risk Summary & Entry Point Confirmation Signals - baoquankhu1.vn

Jan 25, 2026

Jan 21, 2026

Reviewing Biodesix (NASDAQ:BDSX) and HealthEquity (NASDAQ:HQY) - Defense World

Jan 21, 2026

Jan 19, 2026

How geopolitical tensions affect Biodesix Inc. stockWeekly Trade Review & High Accuracy Investment Entry Signals - bollywoodhelpline.com

Jan 19, 2026

Jan 18, 2026

BDSX stock shot up 23% pre-market today — what’s fueling the surge? - MSN

Jan 18, 2026

Jan 16, 2026